1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Definition of response criteria for unidimensional (RECIST), bidimensional (Macdonald), and volumetric techniques
Criteria CR PR SD PD RECIST Resolution of all enhancement ≥30% Decrease in sum of max dimensions All others ≥20% Increase in sum of max dimensions Macdonald Resolution of all enhancement ≥50% Decrease in product of 2 orthogonal dimensions All others ≥25% Increase in product of 2 orthogonal dimensions Volumetric Resolution of all enhancement ≥65% Decrease in volume All others ≥40% Increase in volume
Note:—CR indicates complete response; PR, partial response; SD, stable disease; PD, progression of disease; RECIST, Response Evaluation Criteria in Solid Tumors; max, maximal.